Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment

References

• Bernal-Pacheco O, Limotai N, Go CL, et al. Nonmotor manifestations in Parkinson disease. Neurologist. 2012;18(1):1–16.
   PubMed Web of Science ®Google Scholar
• Wu YH, Chen YH, Chang MH, et al. Depression in Parkinson’s disease: A case-control study. PLoS One. 2018;13:e0192050.
   PubMed Web of Science ®Google Scholar
• Menza M, Dobkin RD, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 2009;72(10):886–892.
   PubMed Web of Science ®Google Scholar
• Richard IH, McDermott MP, Kurlan R, et al. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012;78(16):1229–1236.
   PubMed Web of Science ®Google Scholar
• Lesenskyj AM, Samples MP, Farmer JM, et al. Treating refractory depression in Parkinson's disease: a meta-analysis of transcranial magnetic stimulation. Transl Neurodegener. 2018;7:8
   PubMed Web of Science ®Google Scholar
• Borisovskaya A, Bryson WC, Buchholz J, et al. Electroconvulsive therapy for depression in Parkinson’s disease: systematic review of evidence and recommendations. Neurodegener Dis Manag. 2016;6(2):161–176.
   PubMed Web of Science ®Google Scholar
• Qin B, Chen H, Gao W, et al. Effectiveness of high-frequency repetitive transcranial magnetic stimulation in patients with depression and Parkinson’s disease: A meta-analysis of randomized, controlled clinical trialsd. NDT. 2018;14:273–284.
   Web of Science ®Google Scholar
• Kurtis MM, Rajah T, Delgado LF, et al. The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence. NPJ Park Dis. 2017;3:1–12.
   PubMed Web of Science ®Google Scholar
• Egan SJ, Laidlaw K, Starkstein S. Cognitive behaviour therapy for depression and anxiety in Parkinson’s disease. JPD. 2015;5(3):443–451.
   Web of Science ®Google Scholar
• Xie CL, Wang XD, Chen J, et al. A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson’s disease patients. Neurol Sci. 2015;36(6):833–843.
   PubMed Web of Science ®Google Scholar
• Brewin CR. Theoretical foundations of cognitive-behavior therapy for anxiety and depression. Annu Rev Psychol. 1996;47(1):33–57.
   PubMed Web of Science ®Google Scholar
• Rutten S, Vriend C, Smit JH, et al. Bright light therapy for depression in Parkinson disease: A randomized controlled trial. Neurology. 2019;92(11):e1145–E1156.
   PubMed Web of Science ®Google Scholar
• Xia Y, Wang H-D, Ding Y, et al. Parkinson’s disease combined with depression treated with electroacupuncture and medication and its effect on serum BDNF. Chin Acupunct Moxibustion. 2012;32:1071–1074. http://www.ncbi.nlm.nih.gov/pubmed/23301468.
   Google Scholar
• Ming Wang H, Hui Yang M, Liu Y, et al. Effectiveness of Bushen Huoxue Granule on 5-serotonin and norepinephrine in the brain of Parkinson’s disease patients with depressive state. Chin J Integr Med. 2014;20(12):944–948.
   PubMed Web of Science ®Google Scholar
• Pal E, Nagy F, Aschermann Z, et al. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: A randomized, double-blind, placebo-controlled study. Mov Disord. 2010;25(14):2311–2317.
   PubMed Web of Science ®Google Scholar
• Xiaobo N, Yuanchong G. Observation of repetitively transcranial magnetic stimulation in the treatment of depression induced by Parkinson’s disease. Chin J Pract Nerv Dis. 2012;15:11–13.
   Google Scholar
• Yiping T, Qianqian C, Cao M, et al. A study on high-and low-frequency repetitive transcranial magnetic stimulation in the treatment of Parkinson’s disease complicated with depressive disorder. China Mod Dr. 2015;53:7–10.
   Google Scholar
• Makkos A, Pál E, Aschermann Z, et al. High-frequency repetitive transcranial magnetic stimulation can improve depression in Parkinson’s disease: A Randomized, double-blind, placebo-controlled study. Neuropsychobiology. 2016;73(3):169–177.
   PubMed Web of Science ®Google Scholar
• Brys M, Fox MD, Agarwal S, et al. Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease. Neurology. 2016;87(18):1907–1915.
   PubMed Web of Science ®Google Scholar
• Shin HW, Youn YC, Chung SJ, et al. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson’s disease. J Neurol. 2016;263(7):1442–1448.
   PubMed Web of Science ®Google Scholar
• Guo-Jun Z, Feng T. Efficacy of low-frequency repetitive transcranial magnetic stimulation and setraline in treating Parkinson’s disease patients with depression. Chin J Prim Med Pharm. 2015;22:3314–3317.
   Google Scholar
• Fregni F. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75(8):1171–1174.
   PubMed Web of Science ®Google Scholar
• Boggio PS, Fregni F, Bermpohl F, et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord. 2005;20(9):1178–1184.
   PubMed Web of Science ®Google Scholar
• Cardoso EF, Fregni F, Martins Maia F, et al. rTMS treatment for depression in Parkinson’s disease increases BOLD responses in the left prefrontal cortex. Int J Neuropsychopharmacol. 2008;11:173–183.
   PubMed Web of Science ®Google Scholar
• Sheng-Dong C, Su-Wen Y, Jian-Fa Z, et al. The efficacy of repetitive transcranial magnetic stimulation for PD patients with depression. Chin J Gerontol. 2011;31:3482–3484.
   Google Scholar
• Jun-Min F, Shao-Ming L, Wei G, et al. Optimized combination of low-frequency repetitive transcranial magnetic stimulation for Parkinson’s disease with depression. Hainan Med J. 2012;23:35–38.
   Google Scholar
• Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson’s disease: A randomized, controlled trial. AJP. 2011;168(10):1066–1074.
   Web of Science ®Google Scholar
• Christofoletti G, Cândido ER, Olmedo L, et al. Efeito de uma intervenção cognitivo-motora sobre os sintomas depressivos de pacientes com doença de Parkinson. J Bras Psiquiatr. 2012;61(2):78–83.
   Google Scholar
• Bae ES, Yeum DM. Effect of a Telephone-administered cognitive behavioral therapy for the management of depression, anxiety, and chronic illness anticipated stigma in Parkinson’s disease. Korean J Adult Nurs. 2015;27(2):223.
   Google Scholar
• Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48(5):1398–1403.
   PubMed Web of Science ®Google Scholar
• Fregni F, Ono CR, Santos CM, et al. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology. 2006;66(11):1629–1637.
   PubMed Web of Science ®Google Scholar
• Xie C-L, Chen J, Wang X-D, et al. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials. Neurol Sci. 2015;36(10):1751–1761.
   PubMed Web of Science ®Google Scholar
• Zhang W, Qin S, Guo J, et al. A follow-up fMRI study of a transferable placebo anxiolytic effect. Psychophysiology. 2011;48(8):1119–1128.
   PubMed Web of Science ®Google Scholar
• Avissar M, Powell F, Ilieva I, et al. Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS. Brain Stimul. 2017;10(5):919–925.
   PubMed Web of Science ®Google Scholar
• Ridgel AL, Walter BL, Tatsuoka C, et al. Enhanced exercise therapy in Parkinson’s disease: A comparative effectiveness trial. J Sci Med Sport. 2016;19(1):12–17.
   PubMed Web of Science ®Google Scholar
• Michels K, Dubaz O, Hornthal E, et al. “Dance therapy” as a psychotherapeutic movement intervention in Parkinson’s disease. Complementary Ther Med. 2018;40:248–252.
   PubMed Web of Science ®Google Scholar